IMPORTANCE Early-onset major depressive disorder (MDD) is common in individuals at high familial risk of depression and is associated with poor long-term mental health, social, and educational outcomes.
mon major risk factor for early-onset MDD is depression in a parent. 6, [11] [12] [13] Therefore, the adolescent offspring of depressed parents are an important group for investigating the initial development of early-onset MDD.
Major depressive disorder has a complex multifactorial etiology that includes inherited or familial influences [13] [14] [15] [16] [17] [18] and social risk factors. 8, 9, 19, 20 How do such risks collectively affect the child and eventually translate into first-onset MDD? The childhood symptom dimensions of fear and/or anxiety, depression (low mood), and conduct and oppositional problems have been found to precede later mood disorder. [21] [22] [23] [24] [25] [26] Irritability may be a distinct dimension of oppositional behavior that independently predicts depressive symptoms. [27] [28] [29] Therefore, familial/ genetic and social risk factors may increase the probability of incident MDD through earlier effects on these symptom dimensions that appear to be antecedents to disorder. Despite a consensus that depression has multifactorial causes and likely involves multiple risk pathways that begin in childhood, studies to date have documented elevated lifetime rates of depressive disorder in those at familial risk but have not tested which developmental processes are involved in the initial onset of MDD in these individuals. These data would be informative for refining primary prevention methods. Depression prevention efforts focus on modifying low mood, with promising results when prevention targets those at elevated risk for MDD, including offspring of depressed parents. [30] [31] [32] However, there are different developmental routes to first-onset MDD. If these channels can be identified, targeting relevant risk factors and clinical antecedents could be useful adjuncts to existing prevention programs.
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A focus on identifying processes involved in the first onset of adolescent depression is warranted given the high rates of recurrence when depression arises at this time. 4 To our knowledge, this article is the first to examine the antecedents of the initial onset of MDD during adolescence in a high-risk sample using an approach that models risk factors simultaneously and accounts for the co-occurrence of such risks. We set out to test whether multiple indicators of familial risk and social adversity simultaneously affect first-onset MDD via irritability, disruptive behavior, fear/anxiety, and low mood in a longitudinal study of high-risk child and adolescent offspring of parents with a history of recurrent MDD.
Methods

Participants
Data were from a prospective longitudinal study of the offspring of parents with recurrent depression. At baseline, there were 337 families (315 mothers and 22 fathers) recruited primarily from United Kingdom general practices. 34 The presence of least 2 episodes of DSM-IV MDD in the index parent was confirmed at baseline with a timeline of the parent's previous depressive episodes, 35 To increase confidence that we were identifying firstonset MDD cases, we excluded offspring with a diagnosis of MDD before T1 or at T1 (n = 27), offspring with an episode of MDD that had remitted between follow-up assessments (n = 4), and offspring with missing MDD diagnostic information at baseline (n = 2). These exclusions resulted in a maximum sample of 304 families. Diagnostic data at follow-up were available for 279 of 304 individuals (91.8%).
Secondary Outcome of the Total DSM-IV MDD Symptom Score A total DSM-IV MDD symptom score defined by the CAPA at follow-up was calculated. This number represented the mean of the total symptoms aggregated across T2 and T3.
Antecedent Variables Assessed at Baseline (T1)
Dimensional Clinical Antecedents Low Mood | The Mood and Feelings Questionnaire is a widely accepted depression screening instrument and was used to generate a full range of low mood scores. 40 It includes 34 items about a child's mood symptoms during the past 3 months, rated from 0 (not true) to 2 (true). 40 Scores across informants were combined by using the highest rating per item from the parent or the child. Internal reliability was excellent (α = .95). We did not use the CAPA depression score as a predictor to avoid the possibility of criterion contamination when predicting newonset MDD at follow-up diagnosed using the CAPA and because the threshold for endorsing an MDD symptom is high. Low parent-reported household income was considered a measure of economic disadvantage and was defined as a gross annual family income of £20 000 (US $24 368) or less. 49 In this sample, the amount is equivalent to the international definition of poverty (<60% of the median income).
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Statistical Analysis
Structural equation modeling, which enables simultaneous assessment of all hypothesized risk paths, was performed. The 
Results
Primary Analysis
On average, children and adolescents had a mean (SD) of 1.85 (1.74) (range, 0-8.5) DSM-IV symptoms of MDD at follow-up.
Twenty (6 males and 14 females) had new-onset MDD, with a mean (SD) age at onset of 14.4 (2.0) years (range, 10-18 years) (Table) . Structural equation modeling analysis results for the primary outcome of new-onset offspring MDD are shown in the Figure and are described below.
Dimensional Clinical Antecedents
Irritability was associated with new-onset MDD (β = 0.12, P = .03), as was fear/anxiety (β = 0.38, P < .001). In contrast, allowing for other effects in the full model, neither disruptive behavior (β = −0.08, P = .14) nor low mood (β = −0.03, P =.65) was associated with new-onset MDD. To compare the magnitude of the 2 paths showing significant association with newonset MDD (irritability and fear/anxiety), we constrained them to be equal, which resulted in a significant χ 2 change (χ 2 1 =9.09, P = .003), indicating that the path from fear/anxiety to newonset MDD was significantly stronger. The association between irritability and fear/anxiety was low but significant (β=0 .17 ,P = .001), suggesting that they do not frequently co-occur (Figure) .
Indexes of Familial Risk
The direct paths from additional family history of depression to new-onset MDD (β = 0.10, P = .03) and from parental depression severity to new-onset MDD (β = 0.24, P < .001) were significant. Neither of the indexes of familial risk was associated with the clinical antecedents.
Indexes of Social Risk
Both economic disadvantage (β = 0.12, P = .02) and recent psychosocial adversity (β = 0.22, P < .001) had significant direct effects on new-onset MDD. In addition, economic disadvantage and recent psychosocial adversity were associated with the clinical antecedents.
Indirect Effects
We hypothesized that indexes of familial and social risk would influence risk for new-onset MDD indirectly via the dimensional clinical antecedents, as well as directly. None of the indirect effects were significant, including economic disadvantage to new-onset MDD via irritability (β = 0.007, P = .32), economic disadvantage via fear/anxiety (β = −0.012, P = .43), recent psychosocial adversity via fear/anxiety (β = −0.012, P = .45), and irritability (β = 0.003, P =.57).
Secondary Analysis
The CAPA-derived DSM-IV MDD symptoms were assessed as a secondary outcome (eAppendix in the Supplement). The pattern of the results was similar to the findings for the primary outcome. The only exception was that the paths to MDD symptoms from irritability and from fear/anxiety were not significantly different (χ 2 1 =0 .2 7 ,P = .61). The small number of affected boys (Table) precluded examination of sex differences for new-onset MDD. We thought it important to examine age effects by identifying and excluding prepuberty-onset MDD cases given evidence that they may differ from puberty-onset cases. 22 We also considered excluding cases in which irritability was the defining MDD mood symptom. However, there were no such instances (eAppendix in the Supplement). Additional sensitivity analyses (eAppendix in the Supplement) examined which of the separate aspects of fear/anxiety (generalized anxiety, social anxiety, etc) were most associated with new-onset MDD and whether irritability and fear/anxiety predicted an earlier child or adolescent onset. The results suggested that generalized anxiety symptoms were driving the predictive effect of fear/anxiety on new-onset MDD and that fear/ anxiety (and not irritability) predicted an especially early MDD onset. We predicted that indicators of familial loading and social risk would influence MDD onset indirectly via effects on dimensional clinical antecedents. We did not find such evidence, and all the indirect paths were nonsignificant. In contrast, there were significant direct effects of all familial/ genetic and social risk factors on MDD. Therefore, the indicators of social risk predicted MDD independent of correlated familial risk, parental depression severity, and clinical antecedents in the child. This result has important implications for treatment and prevention and highlights the need to resolve not only clinical phenomena in the child but also wider contextual difficulties. Effective prevention of adolescent MDD is important given the potential for long-term beneficial effects on adult functioning. 63 Our findings suggest that primary prevention methods for depression in groups with high familial risk will need to include effective treatment of parental depression, 30,64,65 irritability, and fear/anxiety in the child and consider social risk factors. Family-based programs may be indicated in children at high familial risk of depression because parental depression is associated with social adversity (poverty and stress exposure) 66-68 and moderates the effectiveness of preventive programs focusing on the child. 30,69 Our results underscore the potent effect of social risks in the initial development of adolescent depression. 49, 66, 70, 71 This study has several important strengths, including a large, prospective longitudinal investigation of children and adolescents at high familial risk of MDD with repeated measurement using comprehensive psychiatric assessments, allowing a novel focus on incident cases of new-onset MDD, low rates of attrition across assessments, and the use of a method appropriate for simultaneously modeling multiple correlated risk effects. However, the results should be interpreted in light of some considerations and limitations.
Limitations
First, although the rates of MDD were higher than those in comparable community studies, 56 participants in this sample had not yet reached the peak period of risk for MDD, which occurs in early adult life; therefore, the numbers with MDD are low. However, the findings were replicated for MDD symptom count. Second, we selected the clinical antecedents and indicators of familial and psychosocial risk on the basis of empirical evidence. 6, 8, 9, 17, 20, 21, 23, 26, 27, 45 It is inevitable that some variables viewed to be important because they are disrupted in major depression (eg, parenting 72 and neuropsychological or cognitive dysfunction 73 ) will have been omitted. Measurement differences between constructs may also contribute to the results (eg, the clinical antecedent construct of fear/ anxiety contained more items than that for irritability). Third, that children evoke economic adversity, and evidence suggests causal effects of psychosocial adversity on MDD when accounting for inherited influences on environmental exposure. 76 Fourth, as would be expected, there were few boys with MDD in the sample, meaning that we were unable to assess sex differences in the pathways to first-onset MDD. Such variations in the pathways to lifetime adult MDD have been reported 77-79 ; therefore, whether there are sex differences in pathways to the incidence of adolescent-onset MDD will require future investigation. Pooled analyses across multiple data sets may be needed to increase sample sizes for such analyses. Fifth, we assessed indicators of familial risk for MDD using data from clinical interviews as opposed to measured genotypes. However, family history provides complementary information to molecular genetic risk scores, which are only weakly predictive at present. 80 Sixth, the sample consisted mostly of depressed mothers, making it unclear whether the findings would generalize to the offspring of depressed fathers, which warrants future investigation.
Conclusions
This study of children and adolescents at high familial risk of MDD shows that irritability and fear/anxiety are important clinical antecedents of new-onset MDD but that familial and social risk factors also contribute to risk for the initial onset of adolescent MDD. Primary depression prevention or early intervention strategies may need to not only target clinical features in the high-risk child and the parent but also incorporate public health and community strategies to help overcome social risks, most notably poverty and psychosocial adversity.
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Additional Contributions: Valerie Russell provided project administration (without compensation outside of her usual salary). Robert Potter, MD, reviewed all cases in which a child had a diagnosis or subthreshold symptoms (without compensation outside of his usual salary). We are grateful to the families and general practitioners who participated in and assisted with this study. We thank the assistant psychologists who helped with data collection. lenge us to prioritize the prevention of child and adolescent depression. As summarized by the authors, the problem is of major public health significance. The study's major contribution is the examination and elucidation of pathways to first-onset major depressive disorder (MDD) in children and adolescents 9 to 17 years old at high risk for depression as indexed by a parental history of at least 2 episodes of MDD. Much extant work has identified those risk factors that place adolescents at highest risk for depression, such as the independent influences of parental depression and low socioeconomic status, both of which increase the hazard ratios 2-fold for adolescent depression. 2 Rice and colleagues 1 uncover multiple possible pathways to first-onset MDD, including indirectly through clinical antecedents categorized as fear/anxiety (β = 0.38, P < .001) and irritability (β = 0.12, P = .03). Most important, those 2 antecedents have not been used as often as low mood (β = −0.03, P = .65 in the present study) in prevention trials to indicate high risk, despite some previous evidence that they are phenotypes that indeed predict the development of depression. For example, Whelan and coworkers 3 found that postnatal maternal depressive symptoms were associated with adolescent irritability symptoms, which in turn correlated with adolescent depressive symptoms (β = 0.11, P < .05). Notably, poverty (β = 0.12, P = .02), severity of parental illness (β = 0.24, P < .001), and psychosocial adversity (β = 0.22, P > .001), as measured by a composite score of recent stressful life events, contribute significantly and directly to first-onset MDD. 1 Therefore, the present study will potentially pave the way for better prevention targets in high-risk youth.
It is critical to pause and reflect on the fact that this study also strengthens previous findings that exposure to parental depression and low socioeconomic status are significant and independent risk factors for youth depression. 4 Clinicians are typically familiar with the concepts of primary, secondary, and tertiary prevention, but fewer are aware of the paradox by Rose, 5 which involves understanding the surprising difference between the effect of individual-level (often termed targeted) vs population-level (often termed universal) prevention approaches. Although population-level risk factors typically have much smaller effect sizes than individuallevel risk factors for a given person (eg, an urban environment vs a family history in a first-degree relative as an individual risk factor for schizophrenia), they paradoxically affect a much larger number of people and thus translate into potentially large effect sizes at the population level. This large influence is intuitively not anticipated, especially not by clinicians, who are still largely trained to think about illnesses at individual levels rather than at population levels. Most reviews of youth depression prevention efforts concur that selective prevention programs (those targeting highrisk individuals) outperform universal intervention programs, which direct efforts at all individuals in a given population. For instance, in their meta-analysis of 32 different depression prevention strategies that mostly used cognitive behavior therapy, stress reduction, and problem-solving techniques, Stice and colleagues 6 concluded that studies targeting adolescents with depression risk factors, such as negative cognitions or anhedonia, had a moderate effect size on average (r = 0.23, P < .001), whereas the mean effect size for universal prevention programs was trivial (r = 0.04, not significant). Ahlen and colleagues 2 explain this finding as predictable because higher-risk adolescents have more room for improvement (hence the larger effects on depressive symptoms of targeted vs universal prevention programs). Although much of the evidence suggests that most of the effect of universal trials is driven by improvement in adolescents with Thus, of the five anxiety dimensions, the stronger predictive effects on new-onset MDD came from generalized anxiety and school avoidance. The full pattern of results when using the generalized anxiety sub-scale as a dimensional clinical antecedent was very similar to that observed for the total anxiety score (results available from first author).
Whilst separation anxiety, social anxiety and panic disorder/somatic symptoms showed significant association with new-onset MDD there were additional independent effects of low mood in those analyses. Finally, we examined whether the clinical antecedents of fear/anxiety and irritability were associated with MDD age-of-onset given previous suggestions that fear/anxiety might be associated with early-onset MDD. Consistent with previous suggestions, we observed an inverse correlation between fear/anxiety and MDD age of onset (r= -.568, p=.009) but not for irritability (r= -.078, p=.745). However, it should be noted that offspring in our study are all children/adolescents so age of onset variation is restricted.
